Novo Nordisk works alongside Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) to improve the development and delivery of life-enhancing and life-saving medicines for patients.
To ensure that patients have confidence in these relationships, the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by Novo Nordisk to HCPs and HCOs.
In-line with current ABPI requirements, Novo Nordisk submits
information regarding transfers of the value made to healthcare
organisations and healthcare professionals to the ABPI central
disclosure platform. For further information, please visit
Statement for the disclosure of 2019 data during the COVID-19 pandemic in 2020
As part of the pharmaceutical industry’s annual disclosure of transfers of value to HCPs, ORDMs and HCOs via the Disclosure UK platform and in order to ensure accuracy of the published data, the ABPI writes to all of the HCPs, ORDMs and HCOs named in companies’ disclosure data ahead of its publication on Disclosure UK at the end of June.
Given the unprecedented pressure on the NHS and health care professionals in responding to the COVID-19 pandemic, in April 2020 the ABPI and PMCPA agreed that it would not be appropriate for industry to write to HCPs, ORDMs or HCOs to request that disclosure data be reviewed. Doing so would add additional work for NHS professionals at this time. To avoid this, and in-line with guidance provided by the ABPI, Novo Nordisk’s 2019 transfer of value data has been published on the Disclosure UK portal in aggregate.
Commitment to transparency
The pharmaceutical industry is committed to preserving the integrity of Disclosure UK and transparency in our interactions with HCPs, ORDMs and HCOs. The ABPI continues to explore how the full disaggregated 2019 data can be submitted to Disclosure UK in line with data from previous years.
Disclosure of 2019 disaggregated data on Novo Nordisk Ltd website
In line with the guidance offered by Disclosure UK, the ABPI and the PMCPA, Novo Nordisk Ltd is publishing disaggregated 2019 disclosure data on the Novo Nordisk Ltd website. The data are available at the following link:
For queries on the data
and/or ToV, please contact
This page is intended for member of the UK public